1. Home
  2. OIS vs STTK Comparison

OIS vs STTK Comparison

Compare OIS & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oil States International Inc.

OIS

Oil States International Inc.

HOLD

Current Price

$9.92

Market Cap

682.7M

Sector

Industrials

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$7.99

Market Cap

569.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OIS
STTK
Founded
1995
2016
Country
United States
United States
Employees
N/A
40
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
682.7M
569.1M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
OIS
STTK
Price
$9.92
$7.99
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$14.00
$10.00
AVG Volume (30 Days)
773.0K
460.4K
Earning Date
04-28-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
53.02
EPS
N/A
N/A
Revenue
$1,088,133,000.00
$1,000,000.00
Revenue This Year
$3.73
N/A
Revenue Next Year
$5.36
N/A
P/E Ratio
N/A
N/A
Revenue Growth
62.26
N/A
52 Week Low
$3.33
$0.71
52 Week High
$14.50
$7.68

Technical Indicators

Market Signals
Indicator
OIS
STTK
Relative Strength Index (RSI) 31.42 75.24
Support Level $5.72 $1.85
Resistance Level $11.88 N/A
Average True Range (ATR) 0.42 0.51
MACD -0.19 0.05
Stochastic Oscillator 0.24 86.25

Price Performance

Historical Comparison
OIS
STTK

About OIS Oil States International Inc.

Oil States International Inc is a provider of manufactured products and services to customers in the energy, military and industrial sectors. The company operates through three business segments - Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. Its customers include many national oil and natural gas companies, and independent oil and natural gas companies, offshore drilling companies and other oilfield service, defense and industrial companies.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: